Association of Cigarette–E-Cigarette Transitions With Respiratory Symptom Resolution
Nicotine and Tobacco Research · 2025
DOI: 10.1093/ntr/ntae224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Jonathan B Berlowitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, Boston University School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Respiratory Sounds, Cough, Vaping. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDA NIH HHS, US Food and Drug Administration's.
Abstract (Originalsprache)
Introduction
Adults increasingly use e-cigarettes for cigarette cessation because of the perceived reduced risk. While e-cigarette use is associated with reduced toxicant exposure compared with smoking, it is unclear whether transitioning from cigarettes to e-cigarettes is associated with resolution of respiratory symptoms.
Methods
Data were obtained from the Population Assessment of Tobacco and Health (PATH) study waves 1–5. US adult participants were separated into observations with cigarette–e-cigarette exposure intervals determined from PATH waves 1–2, 2–3, and 3–4. Observations were included if the participant reported exclusively smoking at baseline and reported a baseline cough or wheeze. Mixed-effect Poisson models measured the association between cigarette–e-cigarette transitions over the two-wave exposure interval (from smoking to nonuse, exclusive e-cigarette use, continued smoking, or dual use) and the reported resolution of the participant’s cough or wheeze.
Results
Among 5210 (3362 unique) observations, transitioning from cigarettes to e-cigarettes was associated with increased rates of wheeze resolution (incidence rate ratio [IRR] = 1.33; 95% confidence interval [CI] = 1.01 to 1.75) but not cough resolution (IRR = 1.18; 95% CI = 0.93 to 1.50) compared with persistent smoking. Cigarette to dual-use transitions were not associated with improvements in symptom resolution, and those who switched to dual use and maintained or increased their smoking intensity had 15% decreased rates of respiratory symptom resolution compared with persistent smoking.
Discussion
E-cigarette-assisted smoking cessation may increase rates of respiratory symptoms resolution among smokers who completely transition to e-cigarettes; however, there is risk for additional harm among those who initiate e-cigarette use without decreasing their smoking intensity.
Implications
Government agencies are increasingly weighing the risks and benefits of e-cigarette-assisted cigarette cessation given the reduced harm associated with e-cigarette use. This study provides novel evidence that completely transitioning from cigarettes to e-cigarettes is associated with increased rates of resolution from self-reported wheeze symptoms. However, risk exists in e-cigarette-assisted cigarette cessation, as those who transitioned from exclusive cigarette smoking to dual use and did not reduce their cigarette smoking intensity had decreased rates of respiratory symptom resolution compared with persistent smokers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Global Health, Boston University School of Public Health, Boston, MA, USA.
- Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
- Population and Global Health, Nanyang Technological University Lee Kong Chian School of Medicine, Singapore.
- Department of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
- Center for Tobacco Research and Intervention, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
- Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
ORCID-Profile: Alyssa F Harlow, Hasmeena Kathuria, Emelia J Benjamin, Andrew C Stokes
Förderung
- NHLBI NIH HHS
- NIDA NIH HHS
- US Food and Drug Administration's
- Center for Tobacco Products
- NIH HHS
- National Heart, Lung, and Blood Institute
- US Food and Drug Administration’s
- National Institute on Drug Abuse
Zitieren
APA
Berlowitz, J. B., Xie, W., Harlow, A. F., Kathuria, H., Benjamin, E. J., & Stokes, A. C. (2025). Association of Cigarette–E-Cigarette Transitions With Respiratory Symptom Resolution. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae224
Vancouver
Berlowitz JB, Xie W, Harlow AF, Kathuria H, Benjamin EJ, Stokes AC. Association of Cigarette–E-Cigarette Transitions With Respiratory Symptom Resolution. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntae224
BibTeX
@article{Berlowitz2025,
author = {Berlowitz, Jonathan B and Xie, Wubin and Harlow, Alyssa F and Kathuria, Hasmeena and Benjamin, Emelia J and Stokes, Andrew C},
title = {Association of Cigarette–E-Cigarette Transitions With Respiratory Symptom Resolution},
journal = {Nicotine and Tobacco Research},
year = {2025},
doi = {10.1093/ntr/ntae224}
}
EUVIMED